Tutorials
Fusion Antibodies PLC logo

Fusion Antibodies PLC

£ 0.85 (-11.46%) Aug 12
P/E:
At Loss
P/B:
5.18
Market Cap:
£ 22.11M ($ 26.85M)
Enterprise V:
£ 20.28M ($ 24.62M)
Volume:
63.23K
Avg Vol (2M):
32.28K
Volume:
63.23K
Market Cap £:
22.11M
Market Cap $:
26.85M
PE Ratio:
At Loss
Avg Vol (2-Month):
32.28K
Enterprise Value £:
20.28M
Enterprise Value $:
24.62M
PB Ratio:
5.18
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Fusion Antibodies PLC
1 Springbank Road, Springbank Industrial Estate, Dunmurry, Belfast, GBR, BT17 0QL
Description
Fusion Antibodies PLC offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development. It is engaged in the research, development, and manufacturing of recombinant proteins particularly in the areas of cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression.
Name Current Vs Industry Vs History
Cash-To-Debt 13.07
Equity-to-Asset 0.79
Debt-to-Equity 0.04
Debt-to-EBITDA -0.26
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 12.11
Distress
Grey
Safe
Beneish M-Score -4.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 54.7
9-Day RSI 66.9
14-Day RSI 70.26
6-1 Month Momentum % -45.68
12-1 Month Momentum % -63.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.09
Quick Ratio 3.57
Cash Ratio 1.84
Days Inventory 73.29
Days Sales Outstanding 90.01
Days Payable 98.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.1

Financials (Next Earnings Date:2022-08-17 Est.)

LSE:FAB's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 4.701
EPS (TTM) (£) -0.118
Beta 0.59
Volatility % 64.86
14-Day RSI 70.26
14-Day ATR (£) 0.092218
20-Day SMA (£) 0.643
12-1 Month Momentum % -63.33
52-Week Range (£) 0.36 - 1.38
Shares Outstanding (Mil) 26.01

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fusion Antibodies PLC Filings

Document Form Filing Date
No Filing Data